Mass General Brigham Gene and Cell Therapy Institute launches RNA Therapeutics Core
Facility launch marks the first time an academic health system is offering on-site, circular RNA manufacturing services to its investigators and industry
2024-09-03
(Press-News.org) The Mass General Brigham Gene and Cell Therapy Institute (GCTI) today announced it has launched the RNA Therapeutics Core, a first-of-its-kind, state-of-the-art facility and resource to advance the use of RNA technologies within and beyond the Mass General Brigham research ecosystem. This new Core is dedicated to accelerating the exploration of novel therapeutic targets to effectively translate RNA-based medicines into clinical practice by leveraging advanced RNA vectors and delivery systems.
Until now, a Core of this kind has not existed within an academic setting. With this launch, the RNA Therapeutics Core enables access to high-quality tools that are critical for researchers who are investigating novel gene and cell therapies. Available to both industry and Mass General Brigham investigators, the Core will provide stock circular RNAs (circRNAs) encoding reporter proteins as well as custom manufactured circRNAs containing almost any sequence of interest. Multiple different RNA vector options are available to support both coding and noncoding applications. The Core has also developed unique codon optimization algorithms that improve protein expression from circRNA beyond existing state of the art algorithms.
CircRNA is a type of single-stranded RNA, which gets its name because of its molecular shape (which forms a continuous loop, unlike linear RNA). CircRNA is found naturally in humans and can have specialized functions within the body. When adapted as a coding RNA technology, circRNA can yield higher levels of protein expression for an extended duration compared to modified linear mRNA, while costing significantly less than mRNA due to its manufacturing simplicity. The Core’s synthetic circRNAs will primarily be used for gene expression and noncoding functions, similar to viruses, plasmids or messenger RNA – elements that are key for developing gene and cell therapies.
“Gene and cell therapy research is paving the way for future, novel treatments for patients with a wide range of critical illnesses, and we believe the application of circular RNA will only help get us even further,” said Nathan Yozwiak PhD, Head of Research, Mass General Brigham GCTI. “We are thrilled to be opening our RNA Therapeutics Core to help advance preclinical research into first-in-human clinical trials – for the hundreds of our own MGB gene and cell researchers, but also industry and investigators at large.”
The Core was created by renowned RNA expert R. Alexander Wesselhoeft, PhD, Director of RNA Therapeutics Core at the Mass General Brigham GCTI. Wesselhoeft created a novel RNA circularization technology while at MIT. His work led to key publications that substantiated the field of synthetic circular RNA and enabled their use for investigative therapeutic applications, and later, co-founded Orna Therapeutics. Under his leadership, the RNA Therapeutics Core will serve to support researchers exploring next-generation RNA medicine platforms and therapeutic applications of circular RNA.
“The range of disease and research areas for which circular RNA can be beneficial is wide-ranging and diverse,” said Wesselhoeft. “From cancer vaccines to transient CAR-T approaches, infectious disease vaccines, tissue regeneration and beyond, our Core is focused on producing high-quality circRNA to support academic research and biotechnological innovation. We have the capability to formulate circRNA into lipid nanoparticles and plan to offer good manufacturing practice grade materials in the future to support the entire spectrum of research and development, from initial discovery to clinical application.”
The Mass General Brigham Gene and Cell Therapy Institute was established in 2022 to fuel the discovery and development of targeted, transformative treatments that have the potential to cure diseases or halt their progression. The Institute unites more than 500 researchers and clinicians dedicated to advancing gene and cell therapy for first-in-human clinical trials, and ultimately, life-saving treatments for patients.
For more information or to place an order, please visit https://researchcores.partners.org/rnac/about.
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-09-03
Valley fever is an emerging fungal disease in the western United States that most often causes flu-like symptoms, but can also cause dangerous or even deadly complications. By analyzing data on reported cases of Valley fever in California, which have increased dramatically over the last two decades, researchers from University of California San Diego and University of California, Berkeley, have identified seasonal patterns that could help individuals and public health officials better prepare for future surges in Valley fever cases. The findings also have important implications for how the changing climate can exacerbate the threat of infectious diseases. The findings are published in The ...
2024-09-03
Natural selection is an important evolutionary force that enables humans to adapt to new environments and fight disease-causing pathogens. However, the unique footprints of natural selection in our genome can be buried beneath those left by other evolutionary forces. Thus, by leveraging information about multiple evolutionary forces, researchers can identify signatures of natural selection in the human genome, and ultimately determine its role in human adaptation and disease.
Low-cost DNA sequencing has ...
2024-09-03
PULLMAN, Wash. -- When young adults first go off to college, more communication with parents generally leads to better relationships, but parents should avoid always initiating it, according to a study led by Washington State University researchers.
In a paper published in the journal Emerging Adulthood, WSU Assistant Professor Jennifer Duckworth and co-authors found that phone, text, video or in-person communication made first-year students feel better about the relationship with their parents. Students also felt better about the relationship when parents offered support or advice, and when they discussed important topics, such as studying and friendships. However, researchers found ...
2024-09-03
A modeling study suggests that one-sided interspecies cooperation can spontaneously emerge and persist over time, despite only one species benefitting. Evolutionary game theory, and the prisoner’s dilemma in particular, are often used to model the evolution of cooperation within a single species. In the prisoner’s dilemma, both parties benefit by cooperating, but the greatest benefit is earned by a defector who plays with a cooperator. The temptation to cheat tends to push players towards defection, ...
2024-09-03
Prostate cancer is the second most common cancer among men worldwide, following lung cancer. In the United States alone, nearly 300,000 new cases are diagnosed annually. While reducing testosterone and other male hormones can be an effective treatment for prostate cancer, this approach becomes ineffective once the disease progresses to metastatic castration-resistant prostate cancer (mCRPC). At this stage, the cancer advances quickly and becomes resistant to conventional hormonal therapies and chemotherapy.
A clever strategy for fighting mCRPC is to exploit the ...
2024-09-03
Around 4 billion years ago, an asteroid hit the Jupiter moon Ganymede. Now, a Kobe University researcher realized that the Solar System's biggest moon's axis has shifted as a result of the impact, which confirmed that the asteroid was around 20 times larger than the one that ended the age of the dinosaurs on Earth, and caused one of the biggest impacts with clear traces in the Solar System.
Ganymede is the largest moon in the Solar System, bigger even than the planet Mercury, and is also interesting for the liquid water oceans beneath its icy surface. Like the Earth’s moon, it is tidally locked, meaning that it always shows the ...
2024-09-03
A sweat-powered wearable has the potential to make continuous, personalized health monitoring as effortless as wearing a Band-Aid. Engineers at the University of California San Diego have developed an electronic finger wrap that monitors vital chemical levels—such as glucose, vitamins, and even drugs—present in the same fingertip sweat from which it derives its energy.
The advance was published Sept. 3 in Nature Electronics by the research group of Joseph Wang, a professor in the Aiiso Yufeng Li Family Department of Chemical and Nano Engineering ...
2024-09-03
Who killed the pregnant porbeagle?
In a marine science version of the game Cluedo, researchers from the US have now accused a larger shark, with its deciduous triangular teeth, in the open sea southwest of Bermuda. This scientific whodunnit is published in Frontiers in Marine Science.
“This is the first documented predation event of a porbeagle shark anywhere in the world,” said lead author Dr Brooke Anderson, a former graduate student at Arizona State University.
“In one event, the population not only lost a reproductive female that could contribute to population growth, but it also lost all her developing ...
2024-09-03
Belching is a common bodily function, but when it escalates to a level that interferes with daily life, it is defined as belching disorders. International surveys have reported that approximately 1% of adults have belching disorders, but the percentage in Japan and the factors involved often elude medical professionals.
To examine the relationship between the rate of belching disorders, comorbidities, and lifestyles in Japan, a research team led by Professor Yasuhiro Fujiwara of Osaka Metropolitan University’s Graduate School of Medicine ...
2024-09-03
Scientists from China have investigated how short peptide chains aggregate together in order to deepen our understanding of the process, which is crucial for drug stability and material development. Their study, published in JACS Au, provides valuable insights into how short proteins called peptides interact, fold, and function. These findings have significant implications for medicine, material science, and biotechnology.
Peptides are short chains of amino acids that play essential roles in the body by building structures, speeding up chemical reactions, and supporting our immune system. The specific function of a protein is determined by how its amino acids interact with each other and ...
LAST 30 PRESS RELEASES:
[Press-News.org] Mass General Brigham Gene and Cell Therapy Institute launches RNA Therapeutics Core
Facility launch marks the first time an academic health system is offering on-site, circular RNA manufacturing services to its investigators and industry
